THE BEST SIDE OF SR9009

[sixty one] shown which the CRISPR/Cas9 process could specially concentrate on and cleave conserved locations during the HBV genome, creating robust suppression of viral gene expression and replication the two in vitro and in vivoThey located that Cas9-mediated base editing is a possible strategy to cure CHB by completely inactivating integrated HB